Fig. 5.
HOXD9 regulates the transition between epithelial and mesenchymal phenotypes in liver cancer cells. a and b Western blot analysis (a) and qRT-PCR analysis (b) showed that silencing HOXD9 causes upregulation of the epithelial cell markers and downregulation of mesenchymal cell markers. c and d Western blot analysis (c) and qRT-PCR analysis (d) show that HOXD9 overexpression leads to the downregulation of epithelial cell markers and upregulation of mesenchymal cell markers. P < 0.01 is based on Student’s t-test. Error bars, SD